Pardes Biosciences, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PRDS research report →
About the company
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, developing, and marketing groundbreaking treatments. The company's core objective is to improve outcomes for patients battling life-threatening illnesses.
- CEO
- Thomas G. Wiggans
- IPO
- 2021
- Employees
- 57
- HQ
- Carlsbad, CA, US
Price Chart
- Market Cap
- $135.19M
- P/E
- -1.35
- P/S
- 0.00
- P/B
- 0.70
- EV/EBITDA
- -0.81
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -41.86%
- ROIC
- -53.57%
- Revenue
- $0 · 0.00%
- Net Income
- $-93,451,000 · -142.43%
- EPS
- $-1.61 · -136.76%
- Op Income
- $-99,817,000
- FCF YoY
- -94.96%
- 52W High
- $3.67
- 52W Low
- $0.75
- 50D MA
- $2.03
- 200D MA
- $1.70
- Beta
- 0.42
- Avg Volume
- 509.69K
Get TickerSpark's AI analysis on PRDS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 31, 23 | Tananbaum James B. | other | 1,000 |
| Aug 31, 23 | Tananbaum James B. | sell | 37,500 |
| Aug 31, 23 | Tananbaum James B. | sell | 75,000 |
| Aug 31, 23 | Tananbaum James B. | sell | 16,813,146 |
| Aug 31, 23 | Tananbaum James B. | sell | 37,500 |
| Aug 31, 23 | WIGGANS THOMAS G | other | 50,000 |
| Aug 31, 23 | WIGGANS THOMAS G | sell | 562,500 |
| Aug 31, 23 | WIGGANS THOMAS G | sell | 985,000 |
| Aug 31, 23 | WIGGANS THOMAS G | sell | 450,000 |
| Aug 31, 23 | Varney Michael David | sell | 37,500 |
Our PRDS coverage
Recent articles, reports, and earnings notes.
No research on PRDS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PRDS report →Similar companies
Peers in the same neighborhood.